Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Oxidative stress biomarkers in Fabry disease: is there a room for them?

Autor: Alessandro Salviati, Irene Simonetta, Costanza Simoncini, Michelangelo Mancuso, V. Cianci, Daniela Concolino, V. Vicenzi, Ginevra De Marchi, Antonino Tuttolomondo, V. Montano, Lucia Chico, Simona Sestito, Marialuisa Zedde, Domenico Girelli, Gabriele Siciliano, Francesco Gruosso, Antonio Pinto, S. Torri

Publikováno v: Journal of Neurology

Background Fabry disease (FD) is an X-linked lysosomal storage disorder, caused by deficient activity of the alpha-galactosidase A enzyme leading to progressive and multisystemic accumulation of globotriaosylceramide. Recent data point toward oxidati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ed1004f69eddd8d64bbe6ac519903c2
https://doi.org/10.1007/s00415-020-10044-w

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Mediterranean winter rainfall in phase with African monsoons during the past 1.36 million years

Autor: Wagner, B. Vogel, H. Francke, A. Friedrich, T. Donders, T. Lacey, J.H. Leng, M.J. Regattieri, E. Sadori, L. Wilke, T. Zanchetta, G. Albrecht, C. Bertini, A. Combourieu-Nebout, N. Cvetkoska, A. Giaccio, B. Grazhdani, A. Hauffe, T. Holtvoeth, J. Joannin, S. Jovanovska, E. Just, J. Kouli, K. Kousis, I. Koutsodendris, A. Krastel, S. Lagos, M. Leicher, N. Levkov, Z. Lindhorst, K. Masi, A. Melles, M. Mercuri, A.M. Nomade, S. Nowaczyk, N. Panagiotopoulos, K. Peyron, O. Reed, J.M. Sagnotti, L. Sinopoli, G. Stelbrink, B. Sulpizio, R. Timmermann, A. Tofilovska, S. Torri, P. Wagner-Cremer, F. Wonik, T. Zhang, X.

Mediterranean climates are characterized by strong seasonal contrasts between dry summers and wet winters. Changes in winter rainfall are critical for regional socioeconomic development, but are difficult to simulate accurately1 and reconstruct on Qu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::b3e380ca8e7bfb3eeca381652c8a15e6
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3056494

Zobrazit plný text záznamu

Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial

Autor: Peters, S. Stahel, R.A. Dafni, U. Ponce Aix, S. Massutí, B. Gautschi, O. Coate, L. López Martín, A. van Heemst, R. Berghmans, T. Meldgaard, P. Cobo Dols, M. Garde Noguera, J. Curioni-Fontecedro, A. Rauch, D. Mark, M.T. Cuffe, S. Biesma, B. van Henten, A.M.J. Juan Vidal, Ó. Palmero Sanchez, R. Villa Guzmán, J.C. Collado Martin, R. Peralta, S. Insa, A. Summers, Y. Láng, I. Horgan, A. Ciardiello, F. de Hosson, S. Pieterman, R. Groen, H.J.M. van den Berg, P.M. Zielinski, C.C. Chittazhathu Kurian Kuruvilla, Y. Gasca-Ruchti, A. Kassapian, M. Novello, S. Torri, V. Tsourti, Z. Gregorc, V. Smit, E.F. EMPHASIS-lung Collaborative Group

Introduction Docetaxel and erlotinib are registered second-line treatments for wild-type EGFR NSCLC. Previous studies suggested a predictive value of the VeriStrat test in second-line therapy of NSCLC, classifying patients as either VeriStrat good or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::0ba1507d0ad73b0dfce28aff8c071fdd
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108791

Zobrazit plný text záznamu

The environmental and evolutionary history of Lake Ohrid (FYROM/Albania): Interim results from the SCOPSCO deep drilling project

Autor: Wagner, B. Wilke, T. Francke, A. Albrecht, C. Baumgarten, H. Bertini, A. Combourieu-Nebout, N. Cvetkoska, A. D'Addabbo, M. Donders, T.H. Föller, K. Giaccio, B. Grazhdani, A. Hauffe, T. Holtvoeth, J. Joannin, S. Jovanovska, E. Just, J. Kouli, K. Koutsodendris, A. Krastel, S. Lacey, J.H. Leicher, N. Leng, M.J. Levkov, Z. Lindhorst, K. Masi, A. Mercuri, A.M. Nomade, S. Nowaczyk, N. Panagiotopoulos, K. Peyron, O. Reed, J.M. Regattieri, E. Sadori, L. Sagnotti, L. Stelbrink, B. Sulpizio, R. Tofilovska, S. Torri, P. Vogel, H. Wagner, T. Wagner-Cremer, F. Wolff, G.A. Wonik, T. Zanchetta, G. Zhang, X.S.

This study reviews and synthesises existing information generated within the SCOPSCO (Scientific Collaboration on Past Speciation Conditions in Lake Ohrid) deep drilling project. The four main aims of the project are to infer (i) the age and origin o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::d6d4f0ac68b60db9e64e8b4b86c6359c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3058597

Zobrazit plný text záznamu

(409) A Double-Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety and Efficacy of NYX-2925 in Subjects with Painful Diabetic Peripheral Neuropathy

Autor: S. Torri, S. Sainati, J. Hamilton, T. Madsen, N. Katz, M. Burak

Publikováno v: The Journal of Pain. 20:S73

NYX-2925, a novel small-molecule modulator of the N-methyl-D-aspartate receptor (NMDAR), was evaluated in a randomized, double-blind, placebo-controlled study, in which 302 subjects with painful DPN received daily oral doses of placebo or NYX-2925 at

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::32409355f588ddbd0c02d1fe87cf76dc
https://doi.org/10.1016/j.jpain.2019.02.094

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Neural plasticity in schizophrenia: An integrated approach for rehabilitation by means of tms and cognitive remediation training

Autor: S. Torriero, C. Gesi, A. Vergallito, C. Mencacci, B. Dell’Osso

Publikováno v: European Psychiatry, Vol 66, Pp S251-S252 (2023)

Introduction Schizophrenia is a severe and disabling psychiatric disorder probably based on complex pathophysiological mechanisms of reduced inhibition, impaired connectivity and reduced plasticity in neural networks. Beside clinical symptomatology,

Externí odkaz: https://doaj.org/article/eb10ef8763574dcea5b262a63c21bf27

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání